RP3128: Clinical Trials

1 trial of RP3128, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow RP3128: new trials by email Literature Review of RP3128 trials Research Report on RP3128

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals
RP3128, Placebo - Healthy Volunteers, Asthma
Phase 1 / Phase 2TerminatedRhizen Pharmaceuticals SA572016-11-032019-10-04

Conditions studied

Asthma (1)

Sponsors

Rhizen Pharmaceuticals SA (1)

Countries

Canada (1)

Results publications

PMID 33314326